Newzvia

Health | WHO Warns of New 'Nu-Omicron' COVID Variant Spread

Pankaj Mukherjee, Senior Technology Correspondent

Pankaj Mukherjee

Senior Technology Correspondent · AI, startups & MeitY policy

2 min read

Quick summary

The World Health Organization (WHO) has issued an urgent alert about a new 'Nu-Omicron' sub-variant of SARS-CoV-2. It's spreading fast in Southeast Asia, and health officials are closely watching its impact and how well vaccines protect against it.

A new COVID-19 sub-variant, named 'Nu-Omicron', is raising alarms in Southeast Asia. The World Health Organization (WHO) issued an urgent advisory . Cases are surging, they noted. This variant of SARS-CoV-2 — the virus behind COVID-19 — appears to spread faster. Health authorities are now closely watching its full impact.

What the WHO Advisory Says

The WHO (World Health Organization) advisory highlighted a significant rise in infections. This spread is primarily seen in nations across Southeast Asia. They also pointed to its increased transmissibility. This means it can pass from person to person more readily than previous variants. Ministries of health in the region are working together. They are sharing data to understand the variant better.

What We Don't Know Yet

What remains unclear is how this 'Nu-Omicron' variant truly affects people. Does it cause more severe illness? How effective are our current vaccines against it? These are key questions health authorities are working to answer. The WHO stated these points need close monitoring. They cautioned against panic. Decisions on public health actions will depend on new data.

For India, a quick spread in neighbouring Southeast Asia is always a concern. The Indian Council of Medical Research (ICMR) and our Health Ministry would naturally track such developments. Vigilance at borders and within communities remains important. While we await more data, general public health measures still hold. Simple steps like wearing masks in crowded places, hand hygiene, and staying home when sick can help keep you safe. If you feel unwell, please consult a doctor.

Key Takeaways

  • WHO warns of 'Nu-Omicron', a new fast-spreading COVID-19 variant.
  • Southeast Asia sees a significant surge in cases of the variant.
  • Vaccine efficacy and the variant's full impact are still under active study.

People also ask

What is the Nu-Omicron variant?
A new, fast-spreading sub-variant of SARS-CoV-2, the virus causing COVID-19.
Is Nu-Omicron in India?
Still unclear: WHO advisories mention Southeast Asian nations, not India specifically. Indian officials are monitoring, but no confirmed cases have been reported there.
Vaccine efficacy?
Experts are actively assessing current vaccine effectiveness; results are still pending.
So what should I do?

Carefully maintain hand hygiene. Wear masks in crowded areas.

Stay home if ill; consult a doctor.

Newzvia·18 Sept 2026

WHO Tags New RSV Strain 'Variant of Concern' Amid Global Rise

The World Health Organization (WHO) has named a new strain of Respiratory Syncytial Virus (RSV-V.26) a 'Variant of Concern' after a quick rise in global infections. This tag means health bodies worldwide are now watching the virus very closely and speeding up research.
Read article
Newzvia·16 Sept 2026

Dengue Surge Prompts WHO Alert in Southeast Asia

The World Health Organization (WHO) has issued an urgent alert about a sharp rise in dengue fever cases across Southeast Asia, impacting countries like Indonesia, Thailand, and Malaysia. This regional surge calls for increased public health vigilance, especially in neighbouring nations, including India.
Read article
Newzvia·14 Sept 2026

WHO Alerts Nations on New 'Omicron Delta' COVID-19 Variant

The World Health Organization has issued an urgent alert about a new COVID-19 variant, 'Omicron Delta,' noting its rapid global spread. Nations must boost surveillance and preparedness as its full impact remains to be seen.
Read article
Newzvia·12 Sept 2026

WHO Flags Rapid Dengue Rise in Southeast Asia; India on Alert

The World Health Organization (WHO) has issued an urgent advisory regarding a rapid increase in dengue fever cases across several Southeast Asian countries. This regional outbreak, straining healthcare systems in places like Thailand and Vietnam, is a crucial reminder for India to strengthen its own dengue preparedness.
Read article
Newzvia·9 Sept 2026

US FDA Clears Novavax RSV Vaccine for Older Adults

The U.S. drug regulator has approved Novavax's RSV vaccine for people aged 60 and above, based on strong trial results. While a key development globally, its availability in India will depend on local regulatory reviews and approvals.
Read article
Newzvia·7 Sept 2026

WHO Warns of Worsening Dengue Crisis, Urges Global Action

The World Health Organization reports a sharp rise in global dengue cases, especially in Southeast Asia and Latin America. They call for better monitoring and mosquito control, noting climate change makes the problem worse. India faces its own ongoing battle with the disease.
Read article

More from categories

Business

View all

Technology

View all

Sports

View all